UPDATE 1-FDA approves biosimilar to J&J's Remicade for multiple diseases

April 5 (Reuters) - The U.S. Food and Drug Administration on

Tuesday approved Inflectra, a cheaper version of Johnson &

Johnson's drug Remicade, to treat Crohn's disease,

ulcerative colitis,...

Read more